Company Secretary Palak Jain resigns from Welcure Drugs

Kmp ResignedManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹0.27

prior close

₹0.27

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%-0.8% vs market

Pharmaceuticals peers, median of 162sector+0.5%-0.5% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.7

10m

+0.0

15m

+3.7

30m

+3.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.8-0.8+0.5-0.5

Next day

+0.0+0.1-0.1+1.5-1.5

+0.0+0.0-0.0+1.1-1.1

-3.7-0.6-3.1+0.8-4.5

-3.7-0.9-2.8+1.0-4.7

-3.7+0.2-3.9+2.7-6.4

+0.0+1.2-1.2+2.3-2.3

15d

-3.7+0.7-4.4+4.3-8.0

-7.4-0.4-7.0+2.6-10.0

-18.5+5.2-23.7+2.9-21.4

-18.5+5.4-23.9+7.6-26.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 162Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ms. Palak Jain has resigned as Company Secretary, Compliance Officer and Key Managerial Personnel of Welcure Drugs & Pharmaceuticals, effective close of business on June 19, 2026. Reason cited is personal reasons and other professional commitments, with no material reasons disclosed. The board recorded appreciation for her contribution. The intimation was signed by Managing Director and CFO Chintan Didawala.

Likely market impact

Loss of a key managerial person. Company must appoint a replacement soon to meet compliance obligations. Minor governance event, no financial impact stated.